Shengxiang Ren
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 5%
- Cancer Research top 0.5%
- Immunology top 2%
- Topics
- Lung Cancer Treatments and Mutations (143 papers)Lung Cancer Research Studies (80 papers)Cancer Immunotherapy and Biomarkers (64 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Shengxiang Ren
240 papers receiving 7.2k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Oncology 4.4k
- Pulmonary and Respiratory Medicine 3.8k
- Molecular Biology 2.4k
- Cancer Research 1.8k
- Immunology 1.1k
Countries citing papers authored by Shengxiang Ren
This map shows the geographic impact of Shengxiang Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengxiang Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengxiang Ren more than expected).
Fields of papers citing papers by Shengxiang Ren
This network shows the impact of papers produced by Shengxiang Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengxiang Ren. The network helps show where Shengxiang Ren may publish in the future.
Co-authorship network of co-authors of Shengxiang Ren
This figure shows the co-authorship network connecting the top 25 collaborators of Shengxiang Ren. A scholar is included among the top collaborators of Shengxiang Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengxiang Ren. Shengxiang Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 6 | |
| 6 | 0 | |
| 7 | 40 | |
| 8 | 12 | |
| 9 | 18 | |
| 10 | 277 | |
| 11 | 121 | |
| 12 | 23 | |
| 13 | 1 | |
| 14 | 34 | |
| 15 | 2 | |
| 16 | 12 | |
| 17 | 8 | |
| 18 | 50 | |
| 19 | 113 | |
| 20 | 60 |
About Shengxiang Ren
Shengxiang Ren is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 249 papers that have together received 7.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (143 papers), Lung Cancer Research Studies (80 papers) and Cancer Immunotherapy and Biomarkers (64 papers). The work is most often cited by research in Oncology (4.4k citations), Cancer Research (1.8k citations) and Pulmonary and Respiratory Medicine (3.8k citations). Shengxiang Ren has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Tao Jiang, Chunxia Su, Xuefei Li, Caicun Zhou, Chao Zhao, Caicun Zhou, Caicun Zhou, Guanghui Gao, Xiaoxia Chen and Fei Zhou. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.